Reid Gregor, Jass Jana, Sebulsky M Tom, McCormick John K
Canadian Research and Development Centre for Probiotics, The Lawson Health Research Institute, London, Ontario N6A 4V2, Canada.
Clin Microbiol Rev. 2003 Oct;16(4):658-72. doi: 10.1128/CMR.16.4.658-672.2003.
Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is now mounting evidence that selected probiotic strains can provide health benefits to their human hosts. Numerous clinical trials show that certain strains can improve the outcome of intestinal infections by reducing the duration of diarrhea. Further investigations have shown benefits in reducing the recurrence of urogenital infections in women, while promising studies in cancer and allergies require research into the mechanisms of activity for particular strains and better-designed trials. At present, only a small percentage of physicians either know of probiotics or understand their potential applicability to patient care. Thus, probiotics are not yet part of the clinical arsenal for prevention and treatment of disease or maintenance of health. The establishment of accepted standards and guidelines, proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization, represents a key step in ensuring that reliable products with suitable, informative health claims become available. Based upon the evidence to date, future advances with single- and multiple-strain therapies are on the horizon for the management of a number of debilitating and even fatal conditions.
益生菌被定义为活的微生物,当给予足够数量时,能给宿主带来健康益处。现在有越来越多的证据表明,选定的益生菌菌株可以为人类宿主提供健康益处。大量临床试验表明,某些菌株可以通过缩短腹泻持续时间来改善肠道感染的结果。进一步的研究表明,这些菌株在减少女性泌尿生殖系统感染复发方面有好处,而在癌症和过敏方面有前景的研究需要深入探究特定菌株的活性机制并开展设计更完善的试验。目前,只有一小部分医生了解益生菌或明白其在患者护理中的潜在适用性。因此,益生菌尚未成为疾病预防和治疗或健康维持的临床手段的一部分。联合国粮食及农业组织和世界卫生组织提议制定公认的标准和指南,这是确保可靠产品带有合适、信息丰富的健康声明得以问世的关键一步。基于目前的证据,单菌株和多菌株疗法在治疗一些使人虚弱甚至致命的疾病方面的未来进展即将出现。